Arizona State Retirement System lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,343 shares of the company’s stock after acquiring an additional 289 shares during the quarter. Arizona State Retirement System’s holdings in HealthEquity were worth $2,432,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently made changes to their positions in HQY. Wealth Enhancement Advisory Services LLC raised its position in shares of HealthEquity by 18.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company’s stock worth $299,000 after acquiring an additional 578 shares during the last quarter. Assetmark Inc. raised its position in shares of HealthEquity by 457.5% during the third quarter. Assetmark Inc. now owns 4,544 shares of the company’s stock worth $372,000 after acquiring an additional 3,729 shares during the last quarter. Covestor Ltd raised its position in shares of HealthEquity by 27.4% during the third quarter. Covestor Ltd now owns 1,524 shares of the company’s stock worth $125,000 after acquiring an additional 328 shares during the last quarter. Los Angeles Capital Management LLC raised its position in shares of HealthEquity by 92.3% during the third quarter. Los Angeles Capital Management LLC now owns 55,597 shares of the company’s stock worth $4,551,000 after acquiring an additional 26,690 shares during the last quarter. Finally, GDS Wealth Management acquired a new stake in HealthEquity during the third quarter worth approximately $2,344,000. 99.55% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several research firms recently commented on HQY. JMP Securities raised their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Raymond James raised their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Finally, Barrington Research raised their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $113.54.
Insider Activity at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.
HealthEquity Stock Down 6.1 %
Shares of NASDAQ:HQY opened at $94.48 on Tuesday. The stock has a market cap of $8.19 billion, a price-to-earnings ratio of 86.68, a PEG ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The business’s 50 day moving average is $105.80 and its 200 day moving average is $94.66.
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the firm posted $0.40 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
- Five stocks we like better than HealthEquity
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- How to Protect Your Portfolio When Inflation Is Rising
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What is a Secondary Public Offering? What Investors Need to Know
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.